Category Archives: Public Policy

Latest From Public Policy

The Critical Importance of International Patent Protection for Small Businesses

Stanley Erck

As part of the implementation of the Leahy-Smith America Invents Act, the U.S. Patent and Trademark Office (PTO) recently held two public hearing on international patent protection.  Stanley C. Erck, President and CEO of Novavax, Inc., testified on behalf of BIO in support of an initiative to reduce filing and prosecution costs for international patent protection of biotech inventions. In his testimony, Mr. Erck explained the important role patents play in the biotechnology industry. The Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Commercialization and Job Creation in the Biotechnology Sector

Doug Crawford

It’s tough presenting programs on technology transfer because so much has already been said that it’s hard to find something new. However, that was not a problem this week in San Francisco at the BIO Technology Transfer Symposium. The Symposium began with an overview of the efforts by the Obama Administration to spur innovation including funding macro and micro grants to encourage the development of regional technology clusters, and proof of concept centers to help Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , ,

EU Stem Cell Patent Decision Hurts Science

Æ

A great article in the Economist titled European science stemmed addresses the recent and controversial decision by the European Court of Justice regarding the patentability of certain inventions derived from embryonic stem cells. ANY country, you might think, would relish being able to call itself the world’s leader in scientific research. America and Europe, however, seem to be in a bizarre parallel contest: which can make its scientists’ lives more difficult by imposing the most muddled Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , ,

CHI Offering Free Webinar on FDA Draft Guidances

chi-logo-btn

The California Healthcare Institute will be hosting a free online discussion on Tuesday, October 25, 2011 that addresses the FDA’s recently released draft guidance documents: Draft Guidance for Industry and Food and Drug Administration Staff – Factors to Consider when Making Benefit-Risk Determinations in Medical Device Premarket Review (Aug. 15, 2011) Draft Guidance for Industry, Clinical Investigators, and Food and Drug Administration Staff – Design Considerations for Pivotal Clinical Investigations for Medical Devices (Aug. 15, 2011) Date: October Read More >

Public Policy  |  2 Comments  |  Email This Post
Tags: , ,

Ten Years After 9/11 and the Anthrax Attacks

Bacillus anthracis

Yesterday, the U.S. Senate Committee on Homeland Security and Governmental Affairs held a hearing entitled, “Ten Years After 9/11 and the Anthrax Attacks: Protecting Against Biological Threats”. As stated by Chairman Lieberman in his opening remarks, the goal of the hearing was to examine whether the federal government “has developed the tools we need to respond effectively to a bioterror attack or naturally-occurring pandemic disease, to develop and disseminate vaccines and antibiotics, and to respond Read More >

Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , ,